Raymond T. Testa - Concepedia

Author

Raymond T. Testa

AstraZeneca (United States)

Also Known As

RAYMOND T. TESTA, Raymond T. Testa, Raymond Testa

Publications

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)Pearl River Community College American Medical Research

About

Raymond T. Testa is an author at AstraZeneca (United States) specializing in medicine, antimicrobial resistance, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	435
2	Biochemistry	5	5	208
3	Natural Sciences	4	4	188
4	Health Sciences	2	2	106
5	Chemical Biology	1	1	18

Raymond T. Testa

Publications

980

Citations

H-Index

Page 1

	Year	Citations
Calicheamicins, a novel family of antitumor antibiotics. 3. Isolation, purification and characterization of calicheamicins .BETA.1Br, .GAMMA.1Br, .ALPHA.2I, .ALPHA.3I, .BETA.1I, .GAMMA.1I and .DELTA.1I. May D. Lee, JOANN K. MANNING, David R. Williams, The Journal of Antibiotics	1989	130
ANTIBIOTIC 6640, A NEW MICROMONOSPORA-PRODUCBD AMINOGLYCOSIDE ANTIBIOTIC Marvin Weinstein, JOSEPH A. MARQUEZ, Raymond T. Testa, The Journal of Antibiotics	1970	129
<i>In Vitro</i> Susceptibility of Characterized β-Lactamase-Producing Strains Tested with Avibactam Combinations Henry Li, Mark Estabrook, George A. Jacoby, Antimicrobial Agents and Chemotherapy	2014	125
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines Phaik‐Eng Sum, Ving J. Lee, Raymond T. Testa, Journal of Medicinal Chemistry Tetracycline Antibacterial AgentsCombinatorial ChemistryPotent Antibacterial AgentsNew GenerationAntimicrobial Chemotherapy	1994	118
<i>In Vitro</i> Activities of Ceftazidime-Avibactam and Aztreonam-Avibactam against 372 Gram-Negative Bacilli Collected in 2011 and 2012 from 11 Teaching Hospitals in China Xiaojuan Wang, Feifei Zhang, Chunjiang Zhao, Antimicrobial Agents and Chemotherapy Extended-spectrum β-LactamasesPseudomonas Aeruginosa IsolatesAntimicrobial ChemotherapyBacterial PathogensAntimicrobial Stewardship	2013	85
In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates Raymond T. Testa, Rafael Cantón, Tommaso Giani, International Journal of Antimicrobial Agents Gram-positive Clinical IsolatesAntibioticsAntibacterial AgentAntimicrobial ChemotherapyMicrobiology	2015	53
MEGALOMICIN, A NEW MACROLIDE ANTIBIOTIC COMPLEX PRODUCED BY MICROMONOSPORA Marvin Weinstein, Gerald H. Wagman, JOSEPH A. MARQUEZ, The Journal of Antibiotics	1969	43
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases Krisztina M. Papp‐Wallace, Saralee Bajaksouzian, Ayman M. Abdelhamed, Diagnostic Microbiology and Infectious Disease Antimicrobial SusceptibilityAntibioticsSingle β-LactamasesMedicineAntibacterial Agent	2015	40
"Glycylcyclines". 3. 9-Aminodoxycyclinecarboxamides Timothy C. Barden, Brian L. Buckwalter, Raymond T. Testa, Journal of Medicinal Chemistry Bioorganic ChemistryAntibiotic AdjuvantGlycobiologyEscherichia ColiAntimicrobial Chemotherapy	1994	35
In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations Ayumi Yoshizumi, Yoshikazu Ishii, Kotaro Aoki, Journal of Infection and Chemotherapy Aztreonam-avibactam CombinationsGram-negative BacteriologyAntimicrobial SusceptibilityAntibioticsMedicine	2014	31

Page 1